NCT00093977 - Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease | Biotech Hunter

Enrollment

1,100

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Kidney DiseaseChronic Kidney Disease

Interventions

DRUG

darbepoetin alfa SF

"Frequency of dosing depends on frequency at randomization:~rHuEPO QW = darbepoetin alfa SF Q2W (dosing conversion table in protocol) rHuEPO biw or tiw = darbepoetin alfa SF QW (dosing conversion table in protocol) darbepoetin alfa RB = darbepoetin alfa SF at same dose and frequency PFS 10, 15, 20, 30, 40, 50, 60, 80, 100, 150, 200 or 300 mcg; Hb maintained between 11.0 - 13.0 g/dL"